Patient P-02338

Synthetic patientMETA-24 · Day 175 · 35–44 · M · baseline S17Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S17

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity+6
GI instability+4
Toxicity+4
Treatment adherence+3
Nutritional resilience+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

53 min

stable · +1.8 vs previous 14 d

Sleep duration

Wearable

6.3 h

stable · -0.1 vs previous 14 d

Energy level

Daily log

6.1/10

worsening · -0.3 vs previous 14 d

Steps

Wearable

5,489

stable · -62 vs previous 14 d

GI burden

Companion

23.9/100

worsening · +4.5 vs previous 14 d

Adherence

Companion

95.6 %

stable · +1.1 vs previous 14 d

Sleep quality

Wearable

25.8/100

worsening · -1.6 vs previous 14 d

Glucose, CGM daily mean

CGM

135 mg/dL

stable · +3.1 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 65 from the failing basin, 24 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -6.3 next day on high-intake days · n 19

Would not help

Keep ultra-processed low
GI +5 next day on high-intake days · n 22

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-6.3supporter · 95%
Ultra-processed food
+5detractor · 95%
Histamine load
+2.3no signal · 47%
Alcohol
-1no signal · 22%
Simple carbohydrates
+0.9no signal · 20%
Dietary fat load
+0.7no signal · 15%
Caffeine
-0.7no signal · 16%
Insoluble fibre
-0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑60
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 29 ms, trending down
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.5 · butyrate capacity 63/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 31 ms
Sleep: 5.9 h
Steps: 5,311
Resting HR: 66 bpm

Daily log: GI score 24, nutritional resilience 67, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02518	51%	S17	DT-01	improved	68
P-02462	43%	S12	DT-01	improved	65
P-02064	42%	S04	SC-12	improved	57
P-02037	41%	S04	GI-04	improved	53
P-02126	41%	S16	DT-01	improved	59
P-02235	41%	S14	DT-01	improved	50
P-02274	41%	S15	DT-01	improved	50
P-02538	41%	S02	GI-04	improved	59
P-02620	41%	S01	HY-01	improved	64
P-02033	40%	S06	GI-04	improved	51
P-02150	40%	S11	HY-01	improved	45
P-02354	40%	S01	CR-01	improved	78